(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) dropped by a staggering 33.33% in 21 sessions from €8.7 to €5.80 at 17:40 EST on Friday, after five successive sessions in a row of losses. CAC 40 is dropping 0.03% to €7,481.30, following the last session’s upward trend.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Earnings Per Share
As for profitability, ABL Diagnostics has a trailing twelve months EPS of €-0.08.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABL Diagnostics’s stock is considered to be overbought (>=80).
Volatility
ABL Diagnostics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 22.48%, a negative 22.48%, and a positive 15.48%.
ABL Diagnostics’s highest amplitude of average volatility was 22.48% (last week), 22.48% (last month), and 15.48% (last quarter).
More news about ABL Diagnostics (ABLD.PA).
